Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, COVID-19 virus infection, Date of authorisation: 25/03/2022, Revision: 2, Status: Authorised
TO: